Pentasa Sachets (mesalazine) are now licensed for use in children with mild to moderate ulcerative colitis, from the age of 6 years.
As a general rule, half the adult dose may be given to children up to a body weight of 40kg, and the normal adult dose to those weighing more than 40kg.
Pentasa Sachets were previously contraindicated under the age of 12 years. The only other mesalazine preparation currently available for use in children is Salofalk Granules.
Further information: Ferring Pharmaceuticals
